Navigation Links
Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
Date:11/1/2010

not take NORVIR with certain medicines, as these can cause serious or life-threatening problems such as irregular heartbeat, breathing difficulties, or excessive sleepiness.  People should not take NORVIR if they have had a serious allergic reaction to any of its ingredients. Some patients taking NORVIR may develop liver and pancreas problems, which can cause death.  Patients may develop large increases in triglycerides and cholesterol, diabetes, high blood sugar, changes in body fat, increased bleeding in people with hemophilia, allergic reactions, and/or changes in heart rhythm. People may develop signs and symptoms of infections that they already have after starting anti-HIV medicines.

Please see the Important Safety Infomation below for more details, including the potential for serious or life-threatening drug interactions.

Please click here for NORVIR full Prescribing Information.  Globally, prescribing information varies; please refer to your individual country's full Prescribing Information for complete information.About EnantaEnanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best in class small molecule drugs in the infectious disease field.  Enanta is developing novel protease, NS5A, polymerase, and cyclophilin-based inhibitors targeted against the Hepatitis C virus (HCV). Additionally, the Company has created a new class of macrolide antibiotics, called Bicyclolides, which overcomes bacterial resistance. Antibacterial focus areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. Enanta is a privately held company headquartered in Watertown, Mass.  Enanta's news releases and other information are a
'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Abbott Again Recognized for Environmental Initiatives in Illinois
2. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
3. Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
4. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
5. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
6. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
7. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
8. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
9. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
10. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
11. Abbott Declares 347th Consecutive Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014  Semler Scientific, Inc. (Nasdaq: ... assessment company that develops patented products that assist ... diseases, today reported financial results for the second ... "The second quarter of 2014 ... Doug Murphy-Chutorian , M.D., chief executive officer of ...
(Date:7/25/2014)... SAN DIEGO , July 25, 2014  Arena ... it will provide a corporate update and report second ... Market opens on Friday, August 1, 2014. That same ... at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). ... by dialing 877.643.7155 for domestic callers and 914.495.8552 for ...
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
Breaking Medicine Technology:Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 2Arena Pharmaceuticals to Host Corporate Update and Financial Results Conference Call and Webcast on Friday, August 1 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4
... , May 20 As the medical device industry gathers ... of Sales Content Management software, offers medical device companies a solution to ... , , ... Sciences at Prolifiq, will lead the workshop "Sales-Friendly Compliant Content Communication: How ...
... NEW YORK , May 19 ... stage, specialty pharmaceutical and medical device company focused on ... Oncology (ASCO) has accepted an oral presentation of Delcath,s ... (PHP-mel) to the best alternative care for patients with hepatic ...
Cached Medicine Technology:Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment 2Prolifiq Offers Best Practices Solution for Selling Medical Devices in Tough Regulatory Environment 3Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago 2Delcath Reconfirms Presentation During American Society of Clinical Oncology 2010 Annual Meeting in Chicago 3
(Date:7/25/2014)... 25, 2014 As reported by the New ... Marijuana Increasing (7/3), the state of Louisiana has recently ... so even than cocaine. Officials believe the increase is due ... a “form” of marijuana. However, both doctors and police confirm ... far as to call it “poison,” doctors have acknowledged that ...
(Date:7/25/2014)... Consuming too much salt? Overloaded on fats, sugars ... labels! , Learn to decipher the valuable information on ... during a "Healthy Eating for You: Label Reading" presentation ... Ohltown Road, Austintown. , Registered dietician and community educator ... questions. , The presentation is free and open ...
(Date:7/25/2014)... (GSA) the nation,s largest interdisciplinary organization devoted ... Heather M. Young, PhD, RN, FAAN, of the ... of the Doris Schwartz Gerontological Nursing Research Award. ... Sciences Section, is given to a member of ... contribution to gerontological nursing research. , The award ...
(Date:7/25/2014)... USA (PRWEB) July 25, 2014 As reported ... Use, OD Deaths Increase (7/20), Michigan has seen a nearly ... four years. While the count was 271 between 1999 and ... range. DEA Agents believe that, like other states, drug users ... the drug via prescription pills. He compared the price of ...
(Date:7/25/2014)... As reported by People Magazine in the article ... Getting Sober (7/15), one of the most popular cast ... to the public about his personal transformation. Now, two years ... that moving on with his life was a challenge. He ... in 2012 and even spent some time in rehab. He ...
Breaking Medicine News(10 mins):Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2Health News:Learn to Decipher Food Labels at Humility House 2Health News:Young earns GSA's 2014 Doris Schwartz Gerontological Nursing Research Award 2Health News:Rise in Heroin Use, Overdose Deaths in Michigan 2Health News:'The Situation' Celebrates 8 Months of Sobriety 2Health News:'The Situation' Celebrates 8 Months of Sobriety 3
... of AED Improves Survival Rates. , ... Rosemont, IL (Vocus) December 30, ... comprehensive emergency action plan (EAP) at an athletic event can mean the ... Cardiac Arrest (SCA) , confirms a study published in the inaugural edition ...
... registered its one-millionth member just 14 months after its launch last ... a more active role in managing their own healthcare. ... ... -- Helping Patients and Physicians , , , "Despite enormous ...
... American Scientific Resources, Inc. (Pink Sheets: ASFX), today announced the ... directors: Mr. Felix Reznick and Ms. Teresa McWilliams, American ... Boston College Law School and the New York ... Boston College Law School (J.D. 1998), and was ...
... 30 Delcath Systems, Inc. (Nasdaq: DCTH ... quarterly update conference call at 4:30 PM Eastern Time ... Chief Executive Officer of Delcath Systems, will host the ... patient enrollment and the advancement of clinical studies. ...
... can revitalize a company or a sports team. Recent research ... body good as well, especially when it comes to fighting ... from the Department of Psychology,s Neuroimmunology Research Unit, discovered that ... stored for less than 9 days increased the odds ...
... Jr., chairman and chief executive officer, Medco Health Solutions, Inc. ... Goldman Sachs Healthcare CEOs Unscripted: A View from the Top ... presentation will begin at 11:15 a.m. EST and Richard J. ... Additionally, Snow will participate on a CEO panel, "Tackling the ...
Cached Medicine News:Health News:Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events 2Health News:Study Stresses Importance of Availability of Automated External Defibrillators at Athletic Events 3Health News: One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org 2Health News: One Million Americans Now Receive Personalized FDA Drug Safety Alerts Through iGuard.org 3Health News:American Scientific Resources Announces Addition of New Board Members 2Health News:Delcath Systems to Host Quarterly Update Conference Call 2Health News:Delcath Systems to Host Quarterly Update Conference Call 3Health News:Young blood fights cancer 2Health News:Young blood fights cancer 3Health News:Medco CEO to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: